Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2003
07/03/2003CA2507870A1 Method of modulating release of saccharides and uses thereof
07/03/2003CA2486930A1 Anti-tirc7 antibodies in therapy of inflammatory diseases
07/03/2003CA2486689A1 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
07/03/2003CA2479263A1 Apomorphine inhibitors of amyloid-.beta. (a.beta.) fibril formation and their use in amyloidosis based disease
07/03/2003CA2473862A1 Pyridoquinoxaline antivirals
07/03/2003CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003CA2471400A1 Vaginal delivery of drugs
07/03/2003CA2471396A1 Ultrapure oral fludara formulation with a fast releasing active substance
07/03/2003CA2471355A1 Substituted diketopiperazines as oxytocin antagonists
07/03/2003CA2471263A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003CA2471120A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003CA2471107A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
07/03/2003CA2471098A1 Pancreatic lipase inhibitor compounds, their synthesis and use
07/03/2003CA2471096A1 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
07/03/2003CA2471089A1 Pyridoquinoxaline antivirals
07/03/2003CA2471087A1 Pyrazolyl-substituted triazoloquinoxalines
07/03/2003CA2471085A1 Aroyl pyridinones
07/03/2003CA2471083A1 Benzhydryl derivatives
07/03/2003CA2471081A1 Formulation & dosage form for the controlled delivery of therapeutic agents
07/03/2003CA2471079A1 Piperidine-2,6-diones heterocyclically substituted in the 3-position
07/03/2003CA2471057A1 Benzothia(dia)zine derivatives and their use as ampa modulators
07/03/2003CA2470999A1 Syn3 compositions and methods
07/03/2003CA2470995A1 Methods of treating bacterial infections in dogs and cats
07/03/2003CA2470976A1 Ph-sensitive polymeric conjugates of an anthracycline drug
07/03/2003CA2470964A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/03/2003CA2470938A1 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2470857A1 Metered dose inhaler
07/03/2003CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003CA2470826A1 Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
07/03/2003CA2470813A1 1,4-dihydro-1,4-diphenylpyridine derivatives
07/03/2003CA2470808A1 Piperazine derivative
07/03/2003CA2470636A1 Zero-order sustained released dosage forms and method of making the same
07/03/2003CA2470612A1 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
07/03/2003CA2470603A1 Methods for the treatment of peripheral neural and vascular ailments
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470591A1 Therapeutic compounds for treating dyslipidemic conditions
07/03/2003CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003CA2470443A1 Pharmaceutical compositions based on azetidine derivatives
07/03/2003CA2470442A1 Method and compositions for treating respiratory pathologies
07/03/2003CA2470364A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
07/03/2003CA2470148A1 Inhibition of tristetraproline for protection of the heart from cardiac injuries
07/03/2003CA2470055A1 Methods for wet granulating azithromycin
07/03/2003CA2470003A1 Composition for treating contact lenses in the eye
07/03/2003CA2469904A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
07/03/2003CA2469884A1 7-amino-benzothiazole derivatives as adenosine receptor ligands
07/03/2003CA2469872A1 Benzothiophenes as adenosine receptor modulators
07/03/2003CA2469551A1 Composition for promotion of bone growth and maintenance of bone health
07/03/2003CA2469372A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production
07/03/2003CA2469370A1 Adipose-derived cell processing unit
07/03/2003CA2469278A1 Isochroman compounds for treatment of cns disorders
07/03/2003CA2469246A1 Directly compressible formulations of azithromycin
07/03/2003CA2469132A1 Staphylococcus aureus exopolysaccharide and process
07/03/2003CA2469047A1 Tempamine compositions and methods of use
07/03/2003CA2469042A1 Triazoles as oxytocin antagonists
07/03/2003CA2468972A1 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene
07/03/2003CA2468775A1 Heparin-containing ophthalmic agent
07/03/2003CA2468627A1 Liposome composition for delivery of nucleic acid
07/03/2003CA2468083A1 Use of heterocyclic carboxamides to treat anemia
07/03/2003CA2467118A1 Aryloxyphenyl and arylsulfanylphenyl derivatives
07/03/2003CA2466928A1 Treatment of neurodegenerative and cardiovascular disorders
07/03/2003CA2463427A1 Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
07/03/2003CA2459300A1 Highly crosslinked biocidal polystyrene hydantoin particles
07/03/2003CA2451993A1 Polypeptide, its conjugate with doxorubicin and conjugate-based pharmaceutical composition
07/03/2003CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/03/2003CA2436850A1 Protease inhibitors
07/02/2003EP1323738A1 Negatively charged polysaccharide derivable form Aloe Vera
07/02/2003EP1323726A1 Erythromycin derivatives and medicines containing the same
07/02/2003EP1323716A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
07/02/2003EP1323714A1 1,3-selenazole derivatives and their use as anticancer drugs or as agrochemicals
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1323436A1 Anti-adhesion barrier comprising carboxymethylcellulose and gellan gum
07/02/2003EP1323433A1 Compositions for preventing urinary calculus
07/02/2003EP1323429A1 Preventives/remedies for emotional disorders
07/02/2003EP1323426A1 Eye drops
07/02/2003EP1323424A1 Buffalo milk gangliosides
07/02/2003EP1323423A1 Combined preparations comprising anthracycline derivatives
07/02/2003EP1323422A1 Pharmaceutical composition comprising midazolam for buccal administration
07/02/2003EP1323421A1 Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence
07/02/2003EP1323420A1 Remedies for inflammatory bowel diseases
07/02/2003EP1323419A1 Airway mucus secretion inhibitors
07/02/2003EP1323418A1 Granular preparations for oral administration
07/02/2003EP1323413A1 Light screening composition comprising a 1,3,5-triazine derivative, a dibenzoylmethane derivative and an amino substituted 2-hydroxybenzophenone derivative
07/02/2003EP1323412A1 Light screening composition comprising a dibenzoylmethane type screening agent and an amino substituted 2-hydroxybenzophenone derivative
07/02/2003EP1322778A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
07/02/2003EP1322755A1 Human and mouse targeting peptides identified by phage display
07/02/2003EP1322748A2 Stem cell differentiation-inducing promoter
07/02/2003EP1322673A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
07/02/2003EP1322663A1 Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5- g(a)-androst-1-en-3-one and a process for preparing it
07/02/2003EP1322661A1 Triterpenes having fungicidal activity against yeast
07/02/2003EP1322660A2 17alpha-fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds
07/02/2003EP1322656A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
07/02/2003EP1322654A1 Platinum complexes as antitumor agents
07/02/2003EP1322652A1 Stereoselective process for preparing cyclohexyl amine derivatives
07/02/2003EP1322651A1 Bicyclic heteroaromatic compounds
07/02/2003EP1322650A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
07/02/2003EP1322648A1 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents
07/02/2003EP1322647A1 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt and process for their preparation
07/02/2003EP1322646A1 2-(1h-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity
07/02/2003EP1322645A2 Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof
1 ... 5419 5420 5421 5422 5423 5424 5425 5426 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 ... 7860